logo
  

Shire To Relocate Over 500 Jobs; Appoints Jeff Poulton As Interim CFO

Shire plc (SHPG,SHP.L) Wednesday said it is shifting more than 500 positions from its Chesterbrook, Pennsylvania site to Lexington, Massachusetts, seeking to realize savings of around $25 million annually from 2016 and achieve greater alignment between its commercial and research and development teams.

The company plans to finish relocating its employees to the Lexington, Massachusetts site, which will be Shire's U.S. operational headquarters, by the first quarter of 2016.

The company also said it has appointed Jeff Poulton, its head of Investor Relations, as its interim chief financial officer, with effect from January 1, 2015.

Shire said Poulton oversaw the rare diseases business unit operations in North America, Latin America, and Asia Pacific. Poulton has worked in finance and business development roles at Cinergy Corp. and PPG Industries prior to joining Shire in 2003.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT